96 related articles for article (PubMed ID: 27623204)
1. Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.
Czapiewski P; Gorczynski A; Radecka K; Wiewiora C; Haybaeck J; Adam P; Fend F; Zakrzewska M; Zakrzewski K; Liberski PP; Biernat W
Pathol Res Pract; 2016 Nov; 212(11):965-971. PubMed ID: 27623204
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
[TBL] [Abstract][Full Text] [Related]
3. TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.
Czapiewski P; Majewska H; Kutzner H; Kazakov D; Renkielska A; Biernat W
Am J Dermatopathol; 2016 Jul; 38(7):513-6. PubMed ID: 27322785
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of PAX5 in medulloblastoma.
Kozmik Z; Sure U; Rüedi D; Busslinger M; Aguzzi A
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5709-13. PubMed ID: 7777574
[TBL] [Abstract][Full Text] [Related]
5. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.
Pratt D; Afsar N; Allgauer M; Fetsch P; Palisoc M; Pittaluga S; Quezado M
Clin Neuropathol; 2017; 36(6):263-271. PubMed ID: 28933335
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Jing CX; Feng Y; Cao X; Xu CG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.
Ren Y; Hou J; Xu A; Pan Y
Int J Clin Exp Pathol; 2015; 8(11):14709-16. PubMed ID: 26823795
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
[TBL] [Abstract][Full Text] [Related]
10. [Expression of the transcription factor PAX5 in childhood acute leukemic cells].
Zhang B; Tie LJ; Ye QD; Gu LJ; Tang JY; Yuan XL; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):6-10. PubMed ID: 16584581
[TBL] [Abstract][Full Text] [Related]
11. PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
Morgan EA; Pozdnyakova O; Nascimento AF; Hirsch MS
Histopathology; 2013 Feb; 62(3):406-13. PubMed ID: 23163626
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of insulin-like growth factor binding protein isoforms in medulloblastoma subtypes and clinical correlation.
Narayan R; Shastry AH; Thota B; Sampath S; Thennarasu K; Arivazhagan A; Santosh V
Pediatr Neurosurg; 2013; 49(6):325-30. PubMed ID: 25427587
[TBL] [Abstract][Full Text] [Related]
13. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
[TBL] [Abstract][Full Text] [Related]
16. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
17. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of β-catenin and stem cell markers as potential prognostic indicators in medulloblastoma.
Gowda KK; Gupta K; Kapoor R; Vasishta RK
Neurol India; 2012; 60(5):487-94. PubMed ID: 23135025
[TBL] [Abstract][Full Text] [Related]
19. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.
de Bont JM; Kros JM; Passier MM; Reddingius RE; Sillevis Smitt PA; Luider TM; den Boer ML; Pieters R
Neuro Oncol; 2008 Oct; 10(5):648-60. PubMed ID: 18577562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
